Journal of Advanced Biomedical Sciences
JABS
Sun, Nov 2, 2025
[Archive]
Volume 15, Issue 4 (10-2025)
J Adv Biomed Sci. 2025, 15(4): 322-323 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Taghinezhad A. From Molecules to Minds: Toward a Multiscale Paradigm in Translational Medicine. J Adv Biomed Sci. 2025; 15 (4) :322-323
URL: http://jabs.fums.ac.ir/article-1-3195-en.html
URL: http://jabs.fums.ac.ir/article-1-3195-en.html
Department of English Language, Fasa University of Medical Sciences, Fasa, Iran , Taghinezhad1@gmail.com
Abstract: (4 Views)
Translational medicine has long aspired to create a seamless continuum from molecular discovery to clinical application. Yet, despite technological advances, progress remains hindered by disciplinary silos. Molecular biology, clinical research, and behavioral science each generate indispensable insights, but too often in isolation. The next phase of biomedical innovation must therefore emphasize integration — a coordinated translation across molecular, physiological, and psychological domains aimed at producing measurable and sustainable improvements in human health.
This issue of the Journal of Advanced Biomedical Sciences reflects that integrative vision. The featured studies demonstrate how molecular mechanisms, clinical observations, and behavioral processes can be synthesized to illuminate the multilevel dynamics of health and disease. Together, they exemplify why integration must evolve from a conceptual ideal to an operational paradigm — one that enhances mechanistic fidelity, improves biomarker predictability, and grounds therapeutic interventions in real-world human contexts.
At the molecular–clinical interface, cardiovascular studies in this issue highlight the essential dialogue between mechanism and medicine. A systematic review reveals how aerobic exercise modulates apoptotic pathways and oxidative stress, reinforcing its dual preventive and therapeutic potential. Complementing this, a clinical trial of ezetimibe–statin combination therapy reports superior LDL-C reduction with acceptable safety, underscoring that molecular rationale and pharmacologic pragmatism must align for optimal outcomes. Here, integration is not rhetorical—it defines how molecular endpoints translate into individualized prescriptions.
COVID-19–related investigations further demonstrate translational synthesis. A case-control study identifies preexisting conditions as predictors of reinfection risk, while retrospective analyses link troponin positivity and reduced ejection fraction with mortality. These findings bridge molecular biomarkers and bedside prognosis, emphasizing that the multisystemic impact of SARS-CoV-2 can only be understood through coordinated molecular, imaging, and clinical surveillance.
This issue of the Journal of Advanced Biomedical Sciences reflects that integrative vision. The featured studies demonstrate how molecular mechanisms, clinical observations, and behavioral processes can be synthesized to illuminate the multilevel dynamics of health and disease. Together, they exemplify why integration must evolve from a conceptual ideal to an operational paradigm — one that enhances mechanistic fidelity, improves biomarker predictability, and grounds therapeutic interventions in real-world human contexts.
At the molecular–clinical interface, cardiovascular studies in this issue highlight the essential dialogue between mechanism and medicine. A systematic review reveals how aerobic exercise modulates apoptotic pathways and oxidative stress, reinforcing its dual preventive and therapeutic potential. Complementing this, a clinical trial of ezetimibe–statin combination therapy reports superior LDL-C reduction with acceptable safety, underscoring that molecular rationale and pharmacologic pragmatism must align for optimal outcomes. Here, integration is not rhetorical—it defines how molecular endpoints translate into individualized prescriptions.
COVID-19–related investigations further demonstrate translational synthesis. A case-control study identifies preexisting conditions as predictors of reinfection risk, while retrospective analyses link troponin positivity and reduced ejection fraction with mortality. These findings bridge molecular biomarkers and bedside prognosis, emphasizing that the multisystemic impact of SARS-CoV-2 can only be understood through coordinated molecular, imaging, and clinical surveillance.
Type of Study: Authors Reply |
Subject:
other
Received: 2025/11/1 | Revised: 2025/11/1 | Accepted: 2025/10/2 | Published: 2025/10/2
Received: 2025/11/1 | Revised: 2025/11/1 | Accepted: 2025/10/2 | Published: 2025/10/2
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This work is licensed under a Creative Commons — Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)